3H-spiperone binding sites in post-mortem brains from schizophrenic patients: relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms. 1989

J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
Department of Psychiatry, University of Würzburg, Federal Republic of Germany.

In post-mortem putamen samples from 27 schizophrenics and 27 controls D2 receptors were measured by Scatchard analysis using 3H-spiperone as a ligand. Maximum number of binding sites (Bmax) and apparent dissociation constant (KD) were significantly increased only in patients in whom neuroleptic medication had been given within a three-month period before death. When the neuroleptic medication had been withdrawn at least 3 month before death, there was a slight, but not significant, reduction in Bmax values and unchanged KD values. Withdrawal of neuroleptic drugs was followed by a normalization of the KD values within 2 weeks and a slower reduction of Bmax values. There were 6 schizophrenic patients with mainly positive schizophrenic symptoms and 17 patients with mainly negative symptoms; positive schizophrenic symptoms were not related to higher Bmax values. There was no difference in 3H-spiperone binding between patients with and without movement disorders (tardive dyskinesia or extrapyramidal symptoms).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder
D013134 Spiperone A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA. Spiroperidol,Spiroperone

Related Publications

J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
August 1978, Life sciences,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
June 1990, Biological psychiatry,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
January 1999, Clinical neuropharmacology,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
January 1992, Psychopharmacology,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
June 1981, Lancet (London, England),
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
May 1981, Lancet (London, England),
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
January 1984, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
August 1978, Life sciences,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
January 1981, Journal of neurochemistry,
J Kornhuber, and P Riederer, and G P Reynolds, and H Beckmann, and K Jellinger, and E Gabriel
August 1978, Nature,
Copied contents to your clipboard!